Values and preferences of the general population in Indonesia in relation to rapid COVID-19 antigen self-tests: A cross-sectional survey

被引:14
作者
Thomas, Caroline [1 ]
Shilton, Sonjelle [2 ]
Thomas, Catherine [1 ]
Batheja, Deepshikha [3 ]
Goel, Srishti [3 ]
Iye, Claudius Mone [1 ]
Ivanova, Elena [2 ]
Martinez-Perez, Guillermo Z. [2 ]
机构
[1] Peduli Hati Bangsa, Jakarta, Indonesia
[2] FIND, Global Alliance Diagnost, Geneva, Switzerland
[3] Ctr Dis Dynam Econ & Policy, New Delhi, India
关键词
COVID-19; home diagnostics; Indonesia; SARS-CoV-2; testing; self-testing; survey;
D O I
10.1111/tmi.13748
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Objectives Home diagnostics are essential to assist members of the general population become active agents of case detection. In Indonesia, a country with an over-burdened healthcare system, individuals could use rapid SARS-CoV-2 antigen tests to self-detect COVID-19. To assess the general population's values and attitudes towards SARS-CoV-2 self-testing, a survey was conducted in mid-2021 in Jakarta and the provinces of Banten and North Sulawesi. Methods This was a quantitative survey that approached respondents in >600 randomly selected street-points in the three study geographies in July-August 2021. A 35-item questionnaire was used to collect data on key variables, such as likelihood to use a SARS-CoV-2 self-test, willingness to pay for a self-test device, and likely actions following a positive self-test result. Bivariate and multivariate regression analyses were performed. Results Of 630 respondents (318 were female), 15.53% knew about COVID-19 self-testing, while 62.70% agreed with the idea of people being able to self-test at home, unassisted, for COVID-19. If self-tests were available in Indonesia, >60% of respondents would use them if they felt it necessary and would undertake regular self-testing for example weekly if recommended. Upon receiving a positive self-test result, most respondents would communicate it (86.03%), request post-test counselling (80.79%), self-isolate (97.46%), and/or warn their close contacts (90.48%). Conclusions The use of rapid SARS-CoV-2 antigen detection tests for self-testing appears acceptable to a majority of the Indonesian public, to learn whether they have COVID-19. Self-testing should be prioritised to complement to an over-burdened healthcare system by helping the public, asymptomatic individuals included, become agents of change in epidemiological surveillance of SARS-CoV-2 in their communities.
引用
收藏
页码:522 / 536
页数:15
相关论文
共 35 条
[1]   Comparative seroprevalence and immunogenicity of six rare serotype recombinant adenovirus vaccine vectors from subgroups B and D [J].
Abbink, Peter ;
Lemckert, Angelique A. C. ;
Ewald, Bonnie A. ;
Lynch, Diana M. ;
Denholtz, Matthew ;
Smits, Shirley ;
Holterman, Lennart ;
Damen, Irma ;
Vogels, Ronald ;
Thorner, Anna R. ;
O'Brien, Kara L. ;
Carville, Angela ;
Mansfield, Keith G. ;
Goudsmit, Jaap ;
Havenga, Menzo J. E. ;
Barouch, Dan H. .
JOURNAL OF VIROLOGY, 2007, 81 (09) :4654-4663
[2]   Care-seeking behaviour among individuals with TB symptoms in Jogjakarta Province, Indonesia: a community-based study [J].
Ahmad, Riris A. ;
Richardus, Jan H. ;
de Vlas, Sake J. .
INTERNATIONAL HEALTH, 2013, 5 (01) :51-57
[3]   Laboratory Readiness and Response for SARS-Cov-2 in Indonesia [J].
Aisyah, Dewi A. N. ;
Mayadewi, Chyntia A. A. ;
Igusti, Gayatri ;
Manikam, Logan ;
Adisasmito, Wiku ;
Kozlakidis, Zisis .
FRONTIERS IN PUBLIC HEALTH, 2021, 9
[4]  
Anastasia T, 2021, FATKA FATKA TENTANG
[5]  
[Anonymous], [No title captured]
[6]  
Barjakova M., 2021, PERCEPTION BEHAVIOUR
[7]  
Better Work Indonesia, COMP GUID COV 19 TRA
[8]   Factors Associated With US Public Motivation to Use and Distribute COVID-19 Self-tests [J].
Bien-Gund, Cedric ;
Dugosh, Karen ;
Acri, Trisha ;
Brady, Kathleen ;
Thirumurthy, Harsha ;
Fishman, Jessica ;
Gross, Robert .
JAMA NETWORK OPEN, 2021, 4 (01)
[9]  
Bio Farma, BIO FARM 10 NUS LAUN
[10]   Beyond COVID-19-will self-sampling and testing become the norm? [J].
Boum, Yap ;
Eyangoh, Sara ;
Okomo, Marie-Claire .
LANCET INFECTIOUS DISEASES, 2021, 21 (09) :1194-1195